A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of RCZY690 in Advanced Solid Tumors
A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of RCZY690 in Advanced Solid Tumors
Not yet recruiting · NCT07806175 · Registry updated 2026-09-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of RCZY690 in Advanced Solid Tumors | Advanced Malignant Solid Tumors | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-08 | NCT07806175 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Rongchang Pharmaceuticals Co., Ltd. | 1 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital, CAMS | Beijing | China | 1 |
| Fudan University Shanghai Cancer Center | Shanghai | China | 85 |
| Hunan Provincial Cancer Hospital | Hunan | China | 1 |
| Shandong Cancer Hospital | Shandong | China | 1 |
| Shanghai Pulmonary Hospital | Shanghai | China | 23 |
| Shanxi Provincial Cancer Hospital | Shanxi | China | 1 |
| Tianjin Medical University Cancer Institute & Hospital | Tianjin | China | 23 |
| Zhejiang Cancer Hospital | Zhejiang | China | 2 |